Tarceva success rate

Common Questions and Answers about Tarceva success rate


Adding Iressa or gefitinib an EGF-R inhibitor (epidermal growth factor receptor) expressed in 50-70% of epithelial ovarian cancers to Topotecan would increase the <span style = 'background-color: #dae8f4'>Success</span> <span style = 'background-color: #dae8f4'>Rate</span> of single Topotecan alone. 3. Iressa is similar to <span style = 'background-color: #dae8f4'>Tarceva</span>. That makes the Avastin/Tarceva trial as effective or much better. In this latter trial you don't have the side effects of a chemo drug which weakens your bone marrow (My wife had Neupogen and platelets transfusions while on Topotecan).
Ovarex MAB is a monoclonal antibody (biologic) is on clinical trial trying to delay recurrence. On phase II it has a <span style = 'background-color: #dae8f4'>Success</span> <span style = 'background-color: #dae8f4'>Rate</span> of 50%. I would say clinical trial is a must if we have to find a cure for OvCA. I wouldn't be surprise if a clinical trial on a combination of Avastin/Tarceva/Phenoxodiol/low dose chemo or chemo combo (can be any combo among Taxol/Carboplatin/Taxotere/Doxil/Gemzar,Topotecan, etc.) would be in the market pretty soon and be a final cure for Ovarian CA. 4.
We have gotten probably at least around five(5) opinions. So we knew that Avastin was the way. 2. Topotecan has almost the same <span style = 'background-color: #dae8f4'>Success</span> <span style = 'background-color: #dae8f4'>Rate</span> as with Doxil. While you know that Doxil worked for my wife, Topo did not. So again case to case. Some women are Successful with it. 3. For platinum-resistant which If I'm not mistaken you are, the Success stories I have been reading on the drug that really works which is non-chemo ( which is good for platimum resistant) is Avastin.
Surveillance for HCC ..... Sorafenib* (Nexavar); Erlotinib (<span style = 'background-color: #dae8f4'>Tarceva</span>); Sirolimus (Rapamune); Capecitabine (Xeloda) ... www.medicine.nevada.edu/homepage/nrg/HCC.ppt Liver Cancer becomes more treatable and Preventable http://www.easl.eu/assets/application/files/85efc16839f275f_file.pdf An Expanded Role for Systemic Therapy in Hepatocellular Carcinoma http://www.primeoncology.org/?PageID=135 AASLD/AGA Institute GastroSlides Unit on Liver Cancer (very large file!) http://www.aasld.